1 Study Coverage 1.1 Depression Medicine Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Introduction 1.2 Global Depression Medicine Outlook 2017 VS 2022 VS 2028 1.2.1 Global Depression Medicine Market Size for the Year 2017-2028 1.2.2 Global Depression Medicine Market Size for the Year 2017-2028 1.3 Depression Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Depression Medicine in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Depression Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Depression Medicine Market Dynamics 1.4.1 Depression Medicine Industry Trends 1.4.2 Depression Medicine Market Drivers 1.4.3 Depression Medicine Market Challenges 1.4.4 Depression Medicine Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Depression Medicine by Type 2.1 Depression Medicine Market Segment by Type 2.1.1 Tricyclic Antidepressants 2.1.2 Serotonin-norepinephrine Inhibitors 2.1.3 Atypical Antipsychotics 2.1.4 Selective Serotonin Reuptake Inhibitors 2.1.5 Benzodiazepines 2.1.6 Tetracyclic Antidepressants 2.1.7 Monoamine Oxidase Inhibitors 2.1.8 Others 2.2 Global Depression Medicine Market Size by Type (2017, 2022 & 2028) 2.3 Global Depression Medicine Market Size by Type (2017-2028) 2.4 United States Depression Medicine Market Size by Type (2017, 2022 & 2028) 2.5 United States Depression Medicine Market Size by Type (2017-2028) 3 Depression Medicine by Application 3.1 Depression Medicine Market Segment by Application 3.1.1 Hospitals 3.1.2 Clinics 3.1.3 Others 3.2 Global Depression Medicine Market Size by Application (2017, 2022 & 2028) 3.3 Global Depression Medicine Market Size by Application (2017-2028) 3.4 United States Depression Medicine Market Size by Application (2017, 2022 & 2028) 3.5 United States Depression Medicine Market Size by Application (2017-2028) 4 Global Depression Medicine Competitor Landscape by Company 4.1 Global Depression Medicine Market Size by Company 4.1.1 Top Global Depression Medicine Companies Ranked by Revenue (2021) 4.1.2 Global Depression Medicine Revenue by Player (2017-2022) 4.2 Global Depression Medicine Concentration Ratio (CR) 4.2.1 Depression Medicine Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Depression Medicine in 2021 4.2.3 Global Depression Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Depression Medicine Headquarters, Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Type 4.3.1 Global Depression Medicine Headquarters and Area Served 4.3.2 Global Depression Medicine Companies Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Depression Medicine Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Depression Medicine Market Size by Company 4.5.1 Top Depression Medicine Players in United States, Ranked by Revenue (2021) 4.5.2 United States Depression Medicine Revenue by Players (2020, 2021 & 2022) 5 Global Depression Medicine Market Size by Region 5.1 Global Depression Medicine Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Depression Medicine Market Size by Region (2017-2028) 5.2.1 Global Depression Medicine Market Size by Region: 2017-2022 5.2.2 Global Depression Medicine Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Depression Medicine Market Size YoY Growth 2017-2028 6.1.2 North America Depression Medicine Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 United States 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Depression Medicine Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Depression Medicine Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Depression Medicine Market Size YoY Growth 2017-2028 6.3.2 Europe Depression Medicine Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Depression Medicine Market Size YoY Growth 2017-2028 6.4.2 Latin America Depression Medicine Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Depression Medicine Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Depression Medicine Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Pfizer 7.1.1 Pfizer Company Details 7.1.2 Pfizer Business Overview 7.1.3 Pfizer Depression Medicine Introduction 7.1.4 Pfizer Revenue in Depression Medicine Business (2017-2022) 7.1.5 Pfizer Recent Development 7.2 AstraZeneca 7.2.1 AstraZeneca Company Details 7.2.2 AstraZeneca Business Overview 7.2.3 AstraZeneca Depression Medicine Introduction 7.2.4 AstraZeneca Revenue in Depression Medicine Business (2017-2022) 7.2.5 AstraZeneca Recent Development 7.3 Eli Lilly and Company 7.3.1 Eli Lilly and Company Company Details 7.3.2 Eli Lilly and Company Business Overview 7.3.3 Eli Lilly and Company Depression Medicine Introduction 7.3.4 Eli Lilly and Company Revenue in Depression Medicine Business (2017-2022) 7.3.5 Eli Lilly and Company Recent Development 7.4 Novartis 7.4.1 Novartis Company Details 7.4.2 Novartis Business Overview 7.4.3 Novartis Depression Medicine Introduction 7.4.4 Novartis Revenue in Depression Medicine Business (2017-2022) 7.4.5 Novartis Recent Development 7.5 GlaxoSmithKline 7.5.1 GlaxoSmithKline Company Details 7.5.2 GlaxoSmithKline Business Overview 7.5.3 GlaxoSmithKline Depression Medicine Introduction 7.5.4 GlaxoSmithKline Revenue in Depression Medicine Business (2017-2022) 7.5.5 GlaxoSmithKline Recent Development 7.6 Otsuka Pharmaceutical 7.6.1 Otsuka Pharmaceutical Company Details 7.6.2 Otsuka Pharmaceutical Business Overview 7.6.3 Otsuka Pharmaceutical Depression Medicine Introduction 7.6.4 Otsuka Pharmaceutical Revenue in Depression Medicine Business (2017-2022) 7.6.5 Otsuka Pharmaceutical Recent Development 7.7 Abbott Laboratories 7.7.1 Abbott Laboratories Company Details 7.7.2 Abbott Laboratories Business Overview 7.7.3 Abbott Laboratories Depression Medicine Introduction 7.7.4 Abbott Laboratories Revenue in Depression Medicine Business (2017-2022) 7.7.5 Abbott Laboratories Recent Development 7.8 Gedeon Richter 7.8.1 Gedeon Richter Company Details 7.8.2 Gedeon Richter Business Overview 7.8.3 Gedeon Richter Depression Medicine Introduction 7.8.4 Gedeon Richter Revenue in Depression Medicine Business (2017-2022) 7.8.5 Gedeon Richter Recent Development 7.9 Janssen Pharmaceuticals 7.9.1 Janssen Pharmaceuticals Company Details 7.9.2 Janssen Pharmaceuticals Business Overview 7.9.3 Janssen Pharmaceuticals Depression Medicine Introduction 7.9.4 Janssen Pharmaceuticals Revenue in Depression Medicine Business (2017-2022) 7.9.5 Janssen Pharmaceuticals Recent Development 7.10 Lupin Pharmaceuticals 7.10.1 Lupin Pharmaceuticals Company Details 7.10.2 Lupin Pharmaceuticals Business Overview 7.10.3 Lupin Pharmaceuticals Depression Medicine Introduction 7.10.4 Lupin Pharmaceuticals Revenue in Depression Medicine Business (2017-2022) 7.10.5 Lupin Pharmaceuticals Recent Development 7.11 Luye Pharma 7.11.1 Luye Pharma Company Details 7.11.2 Luye Pharma Business Overview 7.11.3 Luye Pharma Depression Medicine Introduction 7.11.4 Luye Pharma Revenue in Depression Medicine Business (2017-2022) 7.11.5 Luye Pharma Recent Development 7.12 MSI Methylation Sciences 7.12.1 MSI Methylation Sciences Company Details 7.12.2 MSI Methylation Sciences Business Overview 7.12.3 MSI Methylation Sciences Depression Medicine Introduction 7.12.4 MSI Methylation Sciences Revenue in Depression Medicine Business (2017-2022) 7.12.5 MSI Methylation Sciences Recent Development 7.13 Naurex 7.13.1 Naurex Company Details 7.13.2 Naurex Business Overview 7.13.3 Naurex Depression Medicine Introduction 7.13.4 Naurex Revenue in Depression Medicine Business (2017-2022) 7.13.5 Naurex Recent Development 7.14 SK Biopharmaceuticals 7.14.1 SK Biopharmaceuticals Company Details 7.14.2 SK Biopharmaceuticals Business Overview 7.14.3 SK Biopharmaceuticals Depression Medicine Introduction 7.14.4 SK Biopharmaceuticals Revenue in Depression Medicine Business (2017-2022) 7.14.5 SK Biopharmaceuticals Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Depression Medicine Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Depression Medicine Market Trends Table 3. Depression Medicine Market Drivers Table 4. Depression Medicine Market Challenges Table 5. Depression Medicine Market Restraints Table 6. Global Depression Medicine Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Depression Medicine Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Depression Medicine Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Depression Medicine Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Depression Medicine Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Depression Medicine Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Depression Medicine Revenue Share by Player, 2017-2022 Table 13. Global Depression Medicine Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Depression Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Medicine as of 2021) Table 15. Top Players of Depression Medicine in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Depression Medicine Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Depression Medicine Players in United States Market, Ranking by Revenue (2021) Table 20. United States Depression Medicine Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Depression Medicine Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Depression Medicine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Depression Medicine Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Depression Medicine Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Depression Medicine Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Depression Medicine Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Depression Medicine Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Depression Medicine Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Depression Medicine Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Pfizer Company Details Table 31. Pfizer Business Overview Table 32. Pfizer Depression Medicine Product Table 33. Pfizer Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 34. Pfizer Recent Development Table 35. AstraZeneca Company Details Table 36. AstraZeneca Business Overview Table 37. AstraZeneca Depression Medicine Product Table 38. AstraZeneca Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 39. AstraZeneca Recent Development Table 40. Eli Lilly and Company Company Details Table 41. Eli Lilly and Company Business Overview Table 42. Eli Lilly and Company Depression Medicine Product Table 43. Eli Lilly and Company Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 44. Eli Lilly and Company Recent Development Table 45. Novartis Company Details Table 46. Novartis Business Overview Table 47. Novartis Depression Medicine Product Table 48. Novartis Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 49. Novartis Recent Development Table 50. GlaxoSmithKline Company Details Table 51. GlaxoSmithKline Business Overview Table 52. GlaxoSmithKline Depression Medicine Product Table 53. GlaxoSmithKline Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 54. GlaxoSmithKline Recent Development Table 55. Otsuka Pharmaceutical Company Details Table 56. Otsuka Pharmaceutical Business Overview Table 57. Otsuka Pharmaceutical Depression Medicine Product Table 58. Otsuka Pharmaceutical Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 59. Otsuka Pharmaceutical Recent Development Table 60. Abbott Laboratories Company Details Table 61. Abbott Laboratories Business Overview Table 62. Abbott Laboratories Depression Medicine Product Table 63. Abbott Laboratories Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 64. Abbott Laboratories Recent Development Table 65. Gedeon Richter Company Details Table 66. Gedeon Richter Business Overview Table 67. Gedeon Richter Depression Medicine Product Table 68. Gedeon Richter Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 69. Gedeon Richter Recent Development Table 70. Janssen Pharmaceuticals Company Details Table 71. Janssen Pharmaceuticals Business Overview Table 72. Janssen Pharmaceuticals Depression Medicine Product Table 73. Janssen Pharmaceuticals Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 74. Janssen Pharmaceuticals Recent Development Table 75. Lupin Pharmaceuticals Company Details Table 76. Lupin Pharmaceuticals Business Overview Table 77. Lupin Pharmaceuticals Depression Medicine Product Table 78. Lupin Pharmaceuticals Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 79. Lupin Pharmaceuticals Recent Development Table 80. Luye Pharma Company Details Table 81. Luye Pharma Business Overview Table 82. Luye Pharma Depression Medicine Product Table 83. Luye Pharma Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 84. Luye Pharma Recent Development Table 85. MSI Methylation Sciences Company Details Table 86. MSI Methylation Sciences Business Overview Table 87. MSI Methylation Sciences Depression Medicine Product Table 88. MSI Methylation Sciences Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 89. MSI Methylation Sciences Recent Development Table 90. Naurex Company Details Table 91. Naurex Business Overview Table 92. Naurex Depression Medicine Product Table 93. Naurex Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 94. Naurex Recent Development Table 95. SK Biopharmaceuticals Company Details Table 96. SK Biopharmaceuticals Business Overview Table 97. SK Biopharmaceuticals Depression Medicine Product Table 98. SK Biopharmaceuticals Revenue in Depression Medicine Business (2017-2022) & (US$ Million) Table 99. SK Biopharmaceuticals Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Depression Medicine Product Picture Figure 2. Global Depression Medicine Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Depression Medicine Market Size 2017-2028 (US$ Million) Figure 4. United States Depression Medicine Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Depression Medicine Market Size 2017-2028 (US$ Million) Figure 6. United States Depression Medicine Market Share in Global 2017-2028 Figure 7. Depression Medicine Report Years Considered Figure 8. Product Picture of Tricyclic Antidepressants Figure 9. Product Picture of Serotonin-norepinephrine Inhibitors Figure 10. Product Picture of Atypical Antipsychotics Figure 11. Product Picture of Selective Serotonin Reuptake Inhibitors Figure 12. Product Picture of Benzodiazepines Figure 13. Product Picture of Tetracyclic Antidepressants Figure 14. Product Picture of Monoamine Oxidase Inhibitors Figure 15. Product Picture of Others Figure 16. Global Depression Medicine Market Share by Type in 2022 & 2028 Figure 17. Global Depression Medicine Market Size by Type (2017-2028) & (US$ Million) Figure 18. Global Depression Medicine Market Share by Type (2017-2028) Figure 19. United States Depression Medicine Market Share by Type in 2022 & 2028 Figure 20. United States Depression Medicine Market Size by Type (2017-2028) & (US$ Million) Figure 21. United States Depression Medicine Market Share by Type (2017-2028) Figure 22. Product Picture of Hospitals Figure 23. Product Picture of Clinics Figure 24. Product Picture of Others Figure 25. Global Depression Medicine Market Share by Application in 2022 & 2028 Figure 26. Global Depression Medicine Market Size by Application (2017-2028) & (US$ Million) Figure 27. Global Depression Medicine Market Share by Application (2017-2028) Figure 28. United States Depression Medicine Market Share by Application in 2022 & 2028 Figure 29. United States Depression Medicine Market Size by Application (2017-2028) & (US$ Million) Figure 30. United States Depression Medicine Market Share by Application (2017-2028) Figure 31. North America Depression Medicine Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. United States Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Canada Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Europe Depression Medicine Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. Germany Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. France Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. U.K. Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Italy Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Russia Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Asia-Pacific Depression Medicine Market Size Growth Rate 2017-2028 (US$ Million) Figure 41. China Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Japan Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. South Korea Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. India Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Australia Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. China Taiwan Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Indonesia Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Thailand Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Malaysia Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Latin America Depression Medicine Market Size Growth Rate 2017-2028 (US$ Million) Figure 51. Mexico Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Brazil Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Argentina Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Middle East & Africa Depression Medicine Market Size Growth Rate 2017-2028 (US$ Million) Figure 55. Turkey Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Saudi Arabia Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 57. UAE Depression Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 58. Pfizer Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 59. AstraZeneca Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 60. Eli Lilly and Company Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 61. Novartis Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 62. GlaxoSmithKline Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 63. Otsuka Pharmaceutical Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 64. Abbott Laboratories Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 65. Gedeon Richter Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 66. Janssen Pharmaceuticals Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 67. Lupin Pharmaceuticals Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 68. Luye Pharma Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 69. MSI Methylation Sciences Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 70. Naurex Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 71. SK Biopharmaceuticals Revenue Growth Rate in Depression Medicine Business (2017-2022) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

Pfizer AstraZeneca Eli Lilly and Company Novartis GlaxoSmithKline Otsuka Pharmaceutical Abbott Laboratories Gedeon Richter Janssen Pharmaceuticals Lupin Pharmaceuticals Luye Pharma MSI Methylation Sciences Naurex SK Biopharmaceuticals